Lixian Wu

42 papers and 544 indexed citations i.

About

Lixian Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lixian Wu has authored 42 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Lixian Wu’s work include PARP inhibition in cancer therapy (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and DNA Repair Mechanisms (5 papers). Lixian Wu is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and DNA Repair Mechanisms (5 papers). Lixian Wu collaborates with scholars based in China, United States and Hong Kong. Lixian Wu's co-authors include Jianhua Xu, Lingyu Zhang, Youguang Lu, Dali Zheng, Yuanzhong Chen, Xingyong Chen, Shanshan Lin, Yang Liu, Wenshu Chen and Daohong Zhou and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Co-authorship network of co-authors of Lixian Wu i

Fields of papers citing papers by Lixian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixian Wu. The network helps show where Lixian Wu may publish in the future.

Countries citing papers authored by Lixian Wu

Since Specialization
Citations

This map shows the geographic impact of Lixian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixian Wu more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025